Enzymotec Ltd (NASDAQ:ENZY) had its price objective raised by Jefferies Group from $19.00 to $25.00 in a research report released on Tuesday morning, Stock Ratings Network reports. Jefferies Group currently has a hold rating on the stock.
Jefferies Group has also taken action a number of other stocks recently. The firm upgraded shares of China Petroleum and Chemical from a hold rating to a buy rating. Also, Jefferies Group raised its price target on shares of Transocean from $51.00 to $56.00. They have a hold rating on that stock. Finally, Jefferies Group reiterated its buy rating on shares of CRH PLC.
Shares of Enzymotec Ltd (NASDAQ:ENZY) traded up 2.58% on Tuesday, hitting $24.01. 145,281 shares of the company’s stock traded hands. Enzymotec Ltd has a 52-week low of $14.25 and a 52-week high of $25.50. The stock has a 50-day moving average of $18.71 and a 200-day moving average of $18.71. The company has a market cap of $501.1 million and a price-to-earnings ratio of 54.56.
Enzymotec Ltd (NASDAQ:ENZY) last issued its quarterly earnings data on Monday, November 11th. The company reported $0.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.11 by $0.02. The company had revenue of $22.50 million for the quarter, compared to the consensus estimate of $13.10 million. During the same quarter in the prior year, the company posted $0.10 earnings per share. Analysts expect that Enzymotec Ltd will post $0.48 EPS for the current fiscal year.
ENZY has been the subject of a number of other recent research reports. Analysts at Canaccord Genuity raised their price target on shares of Enzymotec Ltd from $24.00 to $27.00 in a research note to investors on Tuesday. They now have a buy rating on the stock. Separately, analysts at Wedbush raised their price target on shares of Enzymotec Ltd from $21.00 to $27.00 in a research note to investors on Monday. They now have an outperform rating on the stock. Finally, analysts at Merrill Lynch initiated coverage on shares of Enzymotec Ltd in a research note to investors on Tuesday, October 22nd. They set a buy rating and a $21.00 price target on the stock. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The company presently has an average rating of Buy and a consensus target price of $24.20.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.